메뉴 건너뛰기
Nature Clinical Practice Gastroenterology and Hepatology
Volumn 6, Issue 2, 2009, Pages 78-79
What is the safe duration of therapy for patients infected with HCV genotype 6?
Author keywords

[No Author keywords available]
Indexed keywords

INTERFERON; PEGINTERFERON; RIBAVIRIN; VIRUS RNA;
EID: 59949093095     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1335     Document Type: Note
Times cited : (7)
References (8)
  • 1
    • 0037179698 scopus 로고    scopus 로고
    • Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
    • Fried MW et al. (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347: 975-982
    • (2002) N Engl J Med , vol.347 , pp. 975-982
    • Fried, M.W.1
  • 2
    • 0035934568 scopus 로고    scopus 로고
    • Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b for initial treatment of chronic hepatitis C: A randomised trial
    • Manns MP et al. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b for initial treatment of chronic hepatitis C: A randomised trial. Lancet 358: 958-965
    • (2001) Lancet , vol.358 , pp. 958-965
    • Manns, M.P.1
  • 3
    • 2442683905 scopus 로고    scopus 로고
    • Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 and 3
    • Zeuzem S et al. (2004) Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 and 3. J Hepatol 40: 993-999
    • (2004) J Hepatol , vol.40 , pp. 993-999
    • Zeuzem, S.1
  • 4
    • 48749099989 scopus 로고    scopus 로고
    • Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response
    • Ferenci P et al. (2008) Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response. Gastroenterology 135: 451-458
    • (2008) Gastroenterology , vol.135 , pp. 451-458
    • Ferenci, P.1
  • 5
    • 43549108337 scopus 로고    scopus 로고
    • Higher rate of sustained virologic response in chronic hepatitis C genotype 6 treated with 48 weeks versus 24 weeks of peginterferon plus ribavirin
    • Nguyen MH et al. (2008) Higher rate of sustained virologic response in chronic hepatitis C genotype 6 treated with 48 weeks versus 24 weeks of peginterferon plus ribavirin. Am J Gastroenterol 103: 1131-1135
    • (2008) Am J Gastroenterol , vol.103 , pp. 1131-1135
    • Nguyen, M.H.1
  • 6
    • 0037385492 scopus 로고    scopus 로고
    • Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: A comparison with genotype 1
    • Hui CK et al. (2003) Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: A comparison with genotype 1. J Infect Dis 187: 1071-1074
    • (2003) J Infect Dis , vol.187 , pp. 1071-1074
    • Hui, C.K.1
  • 7
    • 0036829499 scopus 로고    scopus 로고
    • Southeast Asian patients with chronic hepatitis C: The impact of novel genotypes and race on treatment outcome
    • Dev AT et al. (2002) Southeast Asian patients with chronic hepatitis C: The impact of novel genotypes and race on treatment outcome. Hepatology 36: 1259-1265
    • (2002) Hepatology , vol.36 , pp. 1259-1265
    • Dev, A.T.1
  • 8
    • 51749084677 scopus 로고    scopus 로고
    • Chronic hepatitis C virus genotype 6 infection: Response to pegylated interferon and ribavirin
    • Fung J et al. (2008) Chronic hepatitis C virus genotype 6 infection: Response to pegylated interferon and ribavirin. J Infect Dis 198: 808-812
    • (2008) J Infect Dis , vol.198 , pp. 808-812
    • Fung, J.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.